Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Resolys Bio

2016 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Angel LATEST DEAL TYPE
$200K LATEST DEAL AMOUNT
Description

Developer of pharmaceutical formulations intended to address chronic disorders.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Other Business Products and Services
Other Industries
Other Consumer Products and Services
Primary Office
  • 545 Westfall Road
  • Delanson, NY 12053
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Resolys Bio’s full profile, request a free trial.

Resolys Bio Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 25-Sep-2017 $200K 00000 Completed Stealth
To view this company’s complete deal history including valuation and funding, request access »

Resolys Bio Executive Team (2)

Name Title Board
Seat
Contact
Info
John McMichael President, Board Member, Secretary & Treasurer
Thomas Hatch Director of Business & Board Member

Resolys Bio Board Members (4)

Name Representing Role Since Contact
Info
Chris Garabedian Resolys Bio Board Member 000 0000
Jeffrey Eckmann Resolys Bio Board Member 000 0000
John McMichael Resolys Bio President, Board Member, Secretary & Treasurer 000 0000
Thomas Hatch Resolys Bio Director of Business & Board Member 000 0000